As of today (2024-05-16), Bioxytran's share price is $0.129. Bioxytran's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.00. Hence, Bioxytran's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for Bioxytran's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Bioxytran's highest Price to Tangible Book Ratio was 8.22. The lowest was 5.75. And the median was 6.99.
BIXT's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.81 * Ranked among companies with meaningful Price-to-Tangible-Book only.
The historical data trend for Bioxytran's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bioxytran's Price-to-Tangible-Book
For the Biotechnology subindustry, Bioxytran's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioxytran's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bioxytran's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Bioxytran's Price-to-Tangible-Book falls into.
Bioxytran Price-to-Tangible-Book Calculation
Bioxytran's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Bioxytran Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Bioxytran's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Bioxytran Inc is a biopharmaceutical company. The company is engaged in developing anti-necrosis drugs that treat a variety of medical conditions resulting from Ischemia. It is also focusing on the development and commercialization of treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. Its product candidate, BXT-25, is an anti-necrosis drug that carries oxygen to tissues when the flow of blood is blocked. Its other drug candidate BXT-252 is a resuscitative agent in a variety of wound healing applications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIXT has been successfully added to your 